{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5fa6e85678bc150948ccfeb4/5fa6e85d4a2a5c52d1e331c6?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Clinical Insights: HCV and Substance Use Disorder","description":"<p style=\"text-align: right;\"><em>Volume 5, Issue 6.</em></p>\n<p>This podcast, Andrew H. Talal, MD, MPH and Richard Blondell, MD from the University at Buffalo discuss expanding HCV screening in persons with substance abuse disorders.</p>\n<p>Take our post-test to claim CME credits:<br />\nPhysician <a href=\"http://dkbmedstream.com/postTestSystem/tests/index.php#213\">post-test</a><br />\nNurse <a href=\"http://dkbmedstream.com/postTestSystem/tests/index.php#214\">post-test</a></p>\n<p>To read a companion newsletter <a href=\"http://eviralhepatitisreview.org/newsletters/volume-5/evh-volume-5-issue-5.html\">click here</a>.</p>\n<p>The post <a rel=\"nofollow\" href=\"https://podcast.dkbmed.com/eviralhepatitis-5-6/\">Clinical Insights: HCV and Substance Use Disorder</a> appeared first on <a rel=\"nofollow\" href=\"https://podcast.dkbmed.com\">DKBmed Radio</a>.</p>","author_name":"eViralHepatitis Review"}